Success Metrics

Completion Rate
0%(0/3)
Active Trials
0(0%)
Terminated
3(43%)

Phase Distribution

Ph phase_2
2
29%
Ph phase_1
5
71%

Phase Distribution

5

Early Stage

2

Mid Stage

0

Late Stage

Phase Distribution7 total trials
Phase 1Safety & dosage
5(71.4%)
Phase 2Efficacy & side effects
2(28.6%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

0.0%

0 of 3 finished

Non-Completion Rate

100.0%

3 ended early

Currently Active

0

trials recruiting

Total Trials

7

all time

Status Distribution
Terminated(3)
Other(4)

Detailed Status

unknown4
Terminated3

Development Timeline

Analytics

Development Status

Total Trials
7
Active
0
Success Rate
0.0%
Most Advanced
Phase 2

Trials by Phase

Phase 15 (71.4%)
Phase 22 (28.6%)

Trials by Status

terminated343%
unknown457%

Recent Activity

0 active trials
Showing 5 of 7
terminatedphase_2

Clinical Trial of TQB2858 Injection in the Treatment of Advanced High-grade Sarcoma

NCT05262101
terminatedphase_1

Study on Tolerability and Pharmacokinetics of TQB2858 Injection in Subjects With Advanced Malignant Tumors

NCT05154630
terminatedphase_1

A Clinical Trial to Evaluate Tolerability and Security of TQB2858 Injection in Subjects With Advanced Pancreatic Carcinoma

NCT05193604
unknownphase_1

To Evaluate the Safety and Efficacy of TQB2858 Injection to the Subjects With Recurrent/Metastatic Nasopharyngeal Cancer

NCT05198531
unknownphase_1

A Clinical Trial to Evaluate Tolerability and Pharmacokinetics of TQB2858 Injection in Subjects With Advanced Malignancy

NCT05068921
View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials
NCT05262101Phase 2

Clinical Trial of TQB2858 Injection in the Treatment of Advanced High-grade Sarcoma

Terminated
NCT05154630Phase 1

Study on Tolerability and Pharmacokinetics of TQB2858 Injection in Subjects With Advanced Malignant Tumors

Terminated
NCT05193604Phase 1

A Clinical Trial to Evaluate Tolerability and Security of TQB2858 Injection in Subjects With Advanced Pancreatic Carcinoma

Terminated
NCT05198531Phase 1

To Evaluate the Safety and Efficacy of TQB2858 Injection to the Subjects With Recurrent/Metastatic Nasopharyngeal Cancer

Unknown
NCT05068921Phase 1

A Clinical Trial to Evaluate Tolerability and Pharmacokinetics of TQB2858 Injection in Subjects With Advanced Malignancy

Unknown
NCT05121363Phase 2

A Clinical Trial to Evaluate TQB2858 Injection Combined With Anlotinib Hydrochloride Capsule in the Treatment of Recurrent or Metastatic Advanced Endometrial Carcinoma

Unknown
NCT04805060Phase 1

A Study to Evaluate the Tolerance and Pharmacokinetics of TQB2858 Injection in Subjects With Terminal Malignant Tumors

Unknown

All 7 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
7